Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Alternative Approaches to Personalized Medicine in Oncology

March 11, 2021 | Biotechnology, Impetus Digital, Laura Towart, My Personal Therapeutics, Natalie Yeadon, cancer patients, cancer therapeutics, digital health, oncology, personalized medicine, precision medicine, tumors 

Laura Towart, Founder & CEO of My Personal Therapeutics, discusses her company’s approach to precision medicine, the barriers patients with cancer face when trying to access personalized treatments, and how the field is expected to change in the near future.

This content was provided by Impetus Digital

Company Details

- PMLiVE

Impetus Digital

Email
Website

 Latest Content from  Impetus Digital 

Courageous Conversations ep.5: Virtual Meetings During the COVID-19 Pandemic

Impetus Digital official statement on COVID-19

At Impetus Digital, the health and wellbeing of our staff, clients, advisors, and their families is always our top priority. Recently, we have seen high numbers of advisors cancel their...

Top 10 Most Important Advisor Questions

Impetus Digital shares its Top 10 list of the most important advisor questions.

Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story

Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club.

Courageous Conversations ep.4: Five Key Benefits of the Internet of Medical Things

Courageous Conversations ep.3: Facial Recognition Technology and Its Impact on Healthcare

Courageous Conversations ep.2: What Our Healthcare System Can Learn from AlphaGo

Courageous Conversations ep.1: Why Our Healthcare System is in Dire Need of Disruption